Simon Woelfel

9PUBLICATIONS
35CO-AUTHORS
AutoimmunityEpigenetics (incl. genome methylation and epigenomics)Innate immunityPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 20, 2026
Anti-Integrin αvβ6 Autoantibodies Distinguish Ulcerative Colitis From Crohn's Disease With High Diagnostic Accuracy and Outperform ANCA and ASCA Status: A Prospective Cross-Sectional Study.

|Aug 12, 2026
Epigenetic modulation of stromal cell states underpins pathological tissue niches in Crohn's disease.

|Jul 30, 2025
XBB.1.5 COVID-19 mRNA Vaccines Induce Inadequate Mucosal Immunity in Patients with Inflammatory Bowel Disease.

Simon Woelfel, Joel Dütschler, Daniel Junker

|Nov 26, 2024
STAR LIGHT Study: XBB.1.5 COVID-19 mRNA Vaccines Boost Systemic but Not Mucosal Immunity Against the SARS-CoV-2 JN.1 Variant in Patients with Chronic Liver Disease.

Simon Woelfel, Daniel Junker, Irina Bergamin

|Oct 29, 2024
XBB.1.5-Adapted COVID-19 mRNA Vaccines but Not Infections With Previous Omicron Variants Boost Neutralisation Against the SARS-CoV-2 JN.1 Variant in Patients With Inflammatory Bowel Disease.

Simon Woelfel, Joel Dütschler, Daniel Junker

|Jul 27, 2024
Systemic and Mucosal Immunogenicity of Monovalent XBB.1.5-Adapted COVID-19 mRNA Vaccines in Patients with Inflammatory Bowel Disease.

Simon Woelfel, Joel Dütschler, Daniel Junker

Pageof 2

Frequent Collaborators

5 joint publications

Stephan Brand

3 joint publications

Katline Metzger-Peter

3 joint publications

Jan Hendrik Niess

3 joint publications

Nicole Schneiderhan-Marra